Research outputs

Published

Medicines Shortages in the United Kingdom

Hughes, D., Oct 2019, In: Clinical Pharmacology and Therapeutics. 106, 4, p. 712

Research output: Contribution to journal › Letter › peer-review

Published

Rapid, Semi-Automated Fractionation of Freshwater Dissolved Organic Carbon Using DAX 8 (XAD 8) and XAD 4 Resins in Tandem

Hughes, D., Holliman, P., Jones, T., Jones, T., Butler, A. J. & Freeman, C., 22 Nov 2016, In: Natural Science. 8, 11, p. 487-498

Research output: Contribution to journal › Article › peer-review

Published

(Lynette writing about) Nesta: Recollection, Reclamation and Reconstruction in Lynette Roberts's Lost Novel

Hughes, D., 20 Dec 2018, In: International Journal of Welsh Writing in English. 5, 2

Research output: Contribution to journal › Article › peer-review

Published

Welsh Literary Modernism, Lynette Roberts and David Jones: "unearthing a huge and very important culture"

Hughes, D., 2 Apr 2019, Locating Lynette Roberts: Always observant and slightly obscure. McAvoy, S. (ed.). University of Wales Press, Cardiff, (Writing Wales in English).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Published

David Jones on Religion, Politics, and Culture: Unpublished Prose

Hughes, D., 1 Oct 2019, In: Modern Language Review. 114, 4, p. 886-887

Research output: Contribution to journal › Book/Film/Article review

Published

Lynette Roberts and the Chronology of Welsh Literary Modernism

Hughes, D., 2014

Research output: Other contribution

Published

InK-Compact: In-Kernel Stream Compaction and Its Application to Multi-Kernel Data Visualization on General-Purpose GPUs

Hughes, D. M., Lim, I. S., Jones, M., Knoll, A. & Spencer, B., 1 Sept 2013, In: Computer Graphics Forum. 32, 6, p. 178-188

Research output: Contribution to journal › Article › peer-review

Published

A case-study of inconsistent surface reconstruction in recent literature resulting from Octree rotation-variance

Hughes, D. M. & Lim, I. S., 1 Jan 2007, p. 195-200.

Research output: Contribution to conference › Paper

Published

Kd-Jump: a Path-Preserving Stackless Traversal for Faster Isosurface Raytracing on GPUs.

Hughes, D. M. & Lim, I. S., 1 Nov 2009, In: IEEE Transactions on visualization and computer graphics. 15, 6, p. 1555-1562

Research output: Contribution to journal › Article › peer-review

Published

Context-preserving rendering of medical segmentation data.

Hughes, D. M. & Lim, I. S., 1 Jan 2007, p. 5521-5524.

Research output: Contribution to conference › Paper

Published

The effects of megafaunal burrows on radiotracer profiles and organic composition in deep sea sediments:preliminary results from two sites in the bathyal north-east Atlantic.

Hughes, D. J., Brown, L., Cook, G. T., Cowie, G., Gage, J. D., Good, E., Kennedy, H. A., MacKenzie, A. B., Papadimitriou, S., Shimmield, G. B., Thomson, J. & Williams, M., 1 Jan 2005, In: Deep Sea Research Part I: Oceanographic Research Papers. 52, 1, p. 1-13

Research output: Contribution to journal › Article › peer-review

Published

Temporal variations in dissolved organic carbon concentrations in upland and lowland lakes in North Wales

Hughes, D. D., Holliman, P. J., Jones, T. & Freeman, C., 1 Jun 2013, In: Water and Environment Journal. 27, 2, p. 275-283

Research output: Contribution to journal › Article › peer-review

Published

Assessment of potential climate change impacts on peatland dissolved organic carbon release and drinking water treatment from laboratory experiments

Hughes, D. D., Tang, R., Clark, J. M., Bond, T., Graham, N., Hughes, D. & Freeman, C., 1 Feb 2013, In: Environmental Pollution. 173, p. 270-277

Research output: Contribution to journal › Article › peer-review

Published

All Wales Medicines Strategy Group Final Assessment Report – Agalsidase alfa (Replagal)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

Evaluation of a consultant audit and feedback programme to improve the quality of antimicrobial prescribing in acute medical admissions

Hughes, D., Roberts, E., Dawoud, D. M., Hughes, D. A. & Cefai, C., 1 Oct 2015, In: International Journal of Pharmacy Practice. 23, 5, p. 333-339

Research output: Contribution to journal › Article › peer-review

Published

Use of PK-PD modelling to predict the impact of non-compliance

Hughes, D. & Hughes, D. A., 1 Nov 2003.

Research output: Contribution to conference › Paper

Published

Ultra-long acting pharmaceuticals: Do they result in better outcomes, and at an acceptable cost?

Hughes, D. & Hughes, D. A., 1 Nov 2006.

Research output: Contribution to conference › Paper

Published

Quantitative risk-benefit analysis

Hughes, D. & Hughes, D. A., 1 May 2007.

Research output: Contribution to conference › Paper

Published

Abolition of prescription copayments in Wales: an observational study on dispensing rates.

Hughes, D., Cohen, D., Alam, M. F., Dunstan, F. D., Myles, S., Hughes, D. A. & Routledge, P. A., 1 Aug 2010, In: Value in Health. 13, 5, p. 675-680

Research output: Contribution to journal › Article › peer-review

Published

Economic evaluations during early (Phase II) drug development: A role for clinical trial simulations.

Hughes, D., Hughes, D. A. & Walley, T., 1 Jan 2001, In: Pharmacoeconomics. 19, 11, p. 1069-1077

Research output: Contribution to journal › Article › peer-review

Published

A parenting programme for children at risk of developing conduct disorder: A cost-effectiveness analysis

Hughes, D., Edwards, R. T., Ceilleachair, A., Bywater, T., Hughes, D. A. & Hutchings, J., 1 May 2007.

Research output: Contribution to conference › Paper

Published

Adverse drug reactions in economic evaluations

Hughes, D. & Hughes, D. A., 1 Jan 2007, In: Value in Health. 10, 3, p. A109

Research output: Contribution to journal › Article › peer-review

Published

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K. & Pirmohamed, M., 1 Jun 2004, In: Pharmacogenetics. 14, 6, p. 335-342

Research output: Contribution to journal › Article › peer-review

Published

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

Hughes, D., Pink, J., Lane, S., Pirmohamed, M. & Hughes D.A., [. V., 31 Oct 2011, In: British Medical Journal. 343, p. 1-14

Research output: Contribution to journal › Article › peer-review

Published

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

Hughes, D., Ramanan, A., Dick, A. D., Benton, D., Compeyrot-Lacassagne, S., Dawoud, D., Hardwick, B., Hickey, H., Hughes, D. A., Jones, A., Woo, P., Edelsten, C., Beresford, M. W. & The SYCAMORE Trail Management Group, [. V., 9 Jan 2014, In: Trials. 15, 14

Research output: Contribution to journal › Article › peer-review

Published

The economics of evergreening.

Hughes, D. & Hughes, D. A., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

The problem of orphan drugs

Hughes, D., Ferner, R. E. & Hughes, D. A., 16 Nov 2010, In: British Medical Journal. 341, p. 335-341

Research output: Contribution to journal › Article › peer-review

Published

Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Nov 2003, In: Value in Health. 6, 6, p. 749

Research output: Contribution to journal › Article › peer-review

Published

All Wales Medicines Strategy Group Final Appraisal Report – Parathyroid hormone (Preotact)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

Drug compliance and pharmaceconomics

Hughes, D. & Hughes, D. A., 1 Dec 2003.

Research output: Contribution to conference › Paper

Published

Impact of the abolition of the prescription charge in Wales

Hughes, D. & Hughes, D. A., 1 Nov 2008.

Research output: Contribution to conference › Paper

Published

A prototype agent-based model of antimalarial drug compliance

Hughes, D., McKean, J., Rahlf, S., Shorter, H., Barnish, G., Paton, R., McBurney, P., Hughes, D. A. & Hastings, I., 1 Aug 2007.

Research output: Contribution to conference › Paper

Published

Economic evaluation during early (phase II) trials

Hughes, D. & Hughes, D. A., 1 Nov 2002.

Research output: Contribution to conference › Paper

Published

Is exercise effective in promoting mental well-being in older age? A systematic review.

Hughes, D., Linck, P. G., Windle, G., Hughes, D. A., Linck, P., Russell, I. T. & Woods, R. T., 1 Aug 2010, In: Aging and Mental Health. 14, 6, p. 652-669

Research output: Contribution to journal › Article › peer-review

Published

Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

Hughes, D., Verhof, T. I., Redekop, W. K., van Schie, R. M., Bayat, S., Daly, A. K., Geitona, M., Haschke-Becher, E., Hughes, D. A., Kamali, F., Levin, L. A., Manolopoulos, V. G., Pirmohamed, M., Siebert, U., Stingl, J. C., Wadelius, M., de Boer, A. & Maitland-van der Zee, A. H., 1 Sept 2012, In: Pharmacogenomics. 13, 12, p. 1405-1417

Research output: Contribution to journal › Article › peer-review

Published

Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments – piloting a discrete choice experiment

Hughes, D., Hughes, D. A., Myles, S., Longo, M. & Lisles, C., 1 Mar 2008

Research output: Non-textual form › Web publication/site

Published

Drugs for exceptionally rare diseases: do they deserve special status for funding?

Hughes, D., Tunnage, B. & Yeo, S. T., 1 Nov 2005, In: QJM - An International Journal of Medicine. 98, 11, p. 829-836

Research output: Contribution to journal › Article › peer-review

Published

All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations.

Hughes, D., Hughes, D. A., Cowell, W., Koncz, T. & Cramer, J., 1 Nov 2007, In: Value in Health. 10, 6, p. 498-509

Research output: Contribution to journal › Article › peer-review

Published

All Wales Medicines Strategy Group Final Appraisal Report - Tenofovir disoproxil fumarate (Viread) for the treatment of hepatitis B.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2008, 2008 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

All Wales Medicines Strategy Group Final Appraisal Report – Dasatinib (Sprycel®) Chronic, accelerated or blast phase CML.

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

Pharmacogenetic tests: the need for a level playing field

Hughes, D., Pirmohamed, M. & Hughes, D. A., 1 Jan 2013, In: Nature Reviews Drug Discovery. 12, 3-4

Research output: Contribution to journal › Article › peer-review

Published

Methodological issues in the literature on costs of non-compliance in chronic diseases

Hughes, D., Salas, M., Zuluaga, A., Hughes, D. A., Cowell, W., Lebmeie, M., Vardeva, K., Pisu, M. & Shinogle, J., 1 Nov 2008.

Research output: Contribution to conference › Paper

Published

Biosimilars: Evidential standards for health technology assessment.

Hughes, D. & Hughes, D. A., 1 Jan 2009.

Research output: Contribution to conference › Paper

Published

The influence of non-compliance on the effectiveness and cost-effectiveness of drug therapies.

Hughes, D. & Hughes, D. A., 1 Jan 2001, 2001 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

Effects of the abolition of prescription charges in Wales: A preliminary analysis

Hughes, D., Hughes, D. A., Alam, F., Cohen, D., Dunstan, F. & Routledge, P., 1 Apr 2008.

Research output: Contribution to conference › Paper

Published

What determines which interventions improve compliance, and do they improve health outcomes in a cost-effective manner?

Hughes, D., Hughes, D. A., LaFleur.*, [. V., Salas, M. & Shinogle, J., 1 May 2007.

Research output: Contribution to conference › Paper

Published

All Wales Medicines Strategy Group Final Appraisal Report – Clofarabine (Evoltra)

Hughes, D., Hughes, D. A. & All Wales Strategy Group., [. V., 1 Jan 2007, 2007 ed. Unknown.

Research output: Book/Report › Commissioned report

Published

Mechanism-Based Approach to the Economic Evaluation of Pharmaceuticals: Pharmacokinetic/Pharmacodynamic/Pharmacoeconomic Analysis of Rituximab for Follicular Lymphoma.

Hughes, D., Pink, J., Lane, S. & Hughes, D. A., 19 Mar 2012, In: Pharmacoeconomics.

Research output: Contribution to journal › Article › peer-review

Published

Back to basics: what is the relationship between dose and duration of drug action?

Hughes, D. & Hughes, D. A., 1 May 2006.

Research output: Contribution to conference › Paper

Research Portal